 | • レポートコード：D0GIR-01568 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ナノ医療の世界市場を広く調査・分析し、今後の市場展望をまとめております。ナノ医療の種類別市場規模（ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス、その他）、用途別市場規模（病院、クリニック、研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott、Mallinckrodt、Merck、GE Healthcare、Celgene、Johnson & Johnson、Teva Pharmaceutical、CombiMatrix、Pfizer、Sigma-Tau Pharmaceuticals、Nanosphere、UCB SA ・地域別グローバル市場分析 2015年-2020年 ・ナノ医療の北米市場（アメリカ、カナダ、メキシコ） ・ナノ医療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ナノ医療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ナノ医療の南米市場（ブラジル、アルゼンチン） ・ナノ医療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス、その他 ・用途別分析：病院、クリニック、研究所 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Nanomedicines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.1% in the forecast period of 2020 to 2025 and will expected to reach USD 195.5 million by 2025, from USD 154.4 million in 2019.
The Nanomedicines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nanomedicines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nanomedicines market has been segmented into:
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
By Application, Nanomedicines has been segmented into:
Hospitals
Clinics
Research Institute
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanomedicines market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanomedicines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanomedicines market.
The report offers in-depth assessment of the growth and other aspects of the Nanomedicines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Nanomedicines Market Share Analysis
Nanomedicines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nanomedicines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanomedicines sales, revenue and market share for each player covered in this report.
The major players covered in Nanomedicines are:
Abbott
Mallinckrodt
Merck
GE Healthcare
Celgene
Johnson & Johnson
Teva Pharmaceutical
CombiMatrix
Pfizer
Sigma-Tau Pharmaceuticals
Nanosphere
UCB SA
Table of Contents
1 Nanomedicines Market Overview
1.1 Product Overview and Scope of Nanomedicines
1.2 Classification of Nanomedicines by Type
1.2.1 Global Nanomedicines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nanomedicines Revenue Market Share by Type in 2019
1.2.3 Nanoparticles
1.2.4 Nanoshells
1.2.5 Nanotubes
1.2.6 Nanodevices
1.2.7 Others
1.3 Global Nanomedicines Market by Application
1.3.1 Overview: Global Nanomedicines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Global Nanomedicines Market by Regions
1.4.1 Global Nanomedicines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nanomedicines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nanomedicines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nanomedicines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nanomedicines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nanomedicines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nanomedicines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mallinckrodt
2.2.1 Mallinckrodt Details
2.2.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mallinckrodt SWOT Analysis
2.2.4 Mallinckrodt Product and Services
2.2.5 Mallinckrodt Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.4 GE Healthcare
2.4.1 GE Healthcare Details
2.4.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GE Healthcare SWOT Analysis
2.4.4 GE Healthcare Product and Services
2.4.5 GE Healthcare Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Celgene SWOT Analysis
2.5.4 Celgene Product and Services
2.5.5 Celgene Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Johnson & Johnson SWOT Analysis
2.6.4 Johnson & Johnson Product and Services
2.6.5 Johnson & Johnson Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceutical
2.7.1 Teva Pharmaceutical Details
2.7.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva Pharmaceutical SWOT Analysis
2.7.4 Teva Pharmaceutical Product and Services
2.7.5 Teva Pharmaceutical Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.8 CombiMatrix
2.8.1 CombiMatrix Details
2.8.2 CombiMatrix Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CombiMatrix SWOT Analysis
2.8.4 CombiMatrix Product and Services
2.8.5 CombiMatrix Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sigma-Tau Pharmaceuticals
2.10.1 Sigma-Tau Pharmaceuticals Details
2.10.2 Sigma-Tau Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sigma-Tau Pharmaceuticals SWOT Analysis
2.10.4 Sigma-Tau Pharmaceuticals Product and Services
2.10.5 Sigma-Tau Pharmaceuticals Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.11 Nanosphere
2.11.1 Nanosphere Details
2.11.2 Nanosphere Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Nanosphere SWOT Analysis
2.11.4 Nanosphere Product and Services
2.11.5 Nanosphere Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
2.12 UCB SA
2.12.1 UCB SA Details
2.12.2 UCB SA Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 UCB SA SWOT Analysis
2.12.4 UCB SA Product and Services
2.12.5 UCB SA Nanomedicines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nanomedicines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nanomedicines Players Market Share
3.2.2 Top 10 Nanomedicines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nanomedicines Revenue and Market Share by Regions
4.2 North America Nanomedicines Revenue and Growth Rate (2015-2020)
4.3 Europe Nanomedicines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nanomedicines Revenue and Growth Rate (2015-2020)
4.5 South America Nanomedicines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nanomedicines Revenue and Growth Rate (2015-2020)
5 North America Nanomedicines Revenue by Countries
5.1 North America Nanomedicines Revenue by Countries (2015-2020)
5.2 USA Nanomedicines Revenue and Growth Rate (2015-2020)
5.3 Canada Nanomedicines Revenue and Growth Rate (2015-2020)
5.4 Mexico Nanomedicines Revenue and Growth Rate (2015-2020)
6 Europe Nanomedicines Revenue by Countries
6.1 Europe Nanomedicines Revenue by Countries (2015-2020)
6.2 Germany Nanomedicines Revenue and Growth Rate (2015-2020)
6.3 UK Nanomedicines Revenue and Growth Rate (2015-2020)
6.4 France Nanomedicines Revenue and Growth Rate (2015-2020)
6.5 Russia Nanomedicines Revenue and Growth Rate (2015-2020)
6.6 Italy Nanomedicines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nanomedicines Revenue by Countries
7.1 Asia-Pacific Nanomedicines Revenue by Countries (2015-2020)
7.2 China Nanomedicines Revenue and Growth Rate (2015-2020)
7.3 Japan Nanomedicines Revenue and Growth Rate (2015-2020)
7.4 Korea Nanomedicines Revenue and Growth Rate (2015-2020)
7.5 India Nanomedicines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nanomedicines Revenue and Growth Rate (2015-2020)
8 South America Nanomedicines Revenue by Countries
8.1 South America Nanomedicines Revenue by Countries (2015-2020)
8.2 Brazil Nanomedicines Revenue and Growth Rate (2015-2020)
8.3 Argentina Nanomedicines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nanomedicines by Countries
9.1 Middle East & Africa Nanomedicines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nanomedicines Revenue and Growth Rate (2015-2020)
9.3 UAE Nanomedicines Revenue and Growth Rate (2015-2020)
9.4 Egypt Nanomedicines Revenue and Growth Rate (2015-2020)
9.5 South Africa Nanomedicines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nanomedicines Revenue and Market Share by Type (2015-2020)
10.2 Global Nanomedicines Market Forecast by Type (2019-2024)
10.3 Nanoparticles Revenue Growth Rate (2015-2025)
10.4 Nanoshells Revenue Growth Rate (2015-2025)
10.5 Nanotubes Revenue Growth Rate (2015-2025)
10.6 Nanodevices Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Nanomedicines Market Segment by Application
11.1 Global Nanomedicines Revenue Market Share by Application (2015-2020)
11.2 Nanomedicines Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Research Institute Revenue Growth (2015-2020)
12 Global Nanomedicines Market Size Forecast (2021-2025)
12.1 Global Nanomedicines Market Size Forecast (2021-2025)
12.2 Global Nanomedicines Market Forecast by Regions (2021-2025)
12.3 North America Nanomedicines Revenue Market Forecast (2021-2025)
12.4 Europe Nanomedicines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nanomedicines Revenue Market Forecast (2021-2025)
12.6 South America Nanomedicines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nanomedicines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Nanomedicines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nanomedicines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nanomedicines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nanomedicines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Nanomedicines Major Business
Table 7. Abbott Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Nanomedicines Product and Solutions
Table 10. Abbott Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mallinckrodt Corporate Information, Location and Competitors
Table 12. Mallinckrodt Nanomedicines Major Business
Table 13. Mallinckrodt Nanomedicines Total Revenue (USD Million) (2018-2019)
Table 14. Mallinckrodt SWOT Analysis
Table 15. Mallinckrodt Nanomedicines Product and Solutions
Table 16. Mallinckrodt Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Nanomedicines Major Business
Table 19. Merck Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Nanomedicines Product and Solutions
Table 22. Merck Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. GE Healthcare Corporate Information, Location and Competitors
Table 24. GE Healthcare Nanomedicines Major Business
Table 25. GE Healthcare Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 26. GE Healthcare SWOT Analysis
Table 27. GE Healthcare Nanomedicines Product and Solutions
Table 28. GE Healthcare Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Celgene Corporate Information, Location and Competitors
Table 30. Celgene Nanomedicines Major Business
Table 31. Celgene Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 32. Celgene SWOT Analysis
Table 33. Celgene Nanomedicines Product and Solutions
Table 34. Celgene Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Johnson & Johnson Corporate Information, Location and Competitors
Table 36. Johnson & Johnson Nanomedicines Major Business
Table 37. Johnson & Johnson Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 38. Johnson & Johnson SWOT Analysis
Table 39. Johnson & Johnson Nanomedicines Product and Solutions
Table 40. Johnson & Johnson Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 42. Teva Pharmaceutical Nanomedicines Major Business
Table 43. Teva Pharmaceutical Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 44. Teva Pharmaceutical SWOT Analysis
Table 45. Teva Pharmaceutical Nanomedicines Product and Solutions
Table 46. Teva Pharmaceutical Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. CombiMatrix Corporate Information, Location and Competitors
Table 48. CombiMatrix Nanomedicines Major Business
Table 49. CombiMatrix Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 50. CombiMatrix SWOT Analysis
Table 51. CombiMatrix Nanomedicines Product and Solutions
Table 52. CombiMatrix Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Pfizer Corporate Information, Location and Competitors
Table 54. Pfizer Nanomedicines Major Business
Table 55. Pfizer Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 56. Pfizer SWOT Analysis
Table 57. Pfizer Nanomedicines Product and Solutions
Table 58. Pfizer Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Sigma-Tau Pharmaceuticals Corporate Information, Location and Competitors
Table 60. Sigma-Tau Pharmaceuticals Nanomedicines Major Business
Table 61. Sigma-Tau Pharmaceuticals Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 62. Sigma-Tau Pharmaceuticals SWOT Analysis
Table 63. Sigma-Tau Pharmaceuticals Nanomedicines Product and Solutions
Table 64. Sigma-Tau Pharmaceuticals Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Nanosphere Corporate Information, Location and Competitors
Table 66. Nanosphere Nanomedicines Major Business
Table 67. Nanosphere Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 68. Nanosphere SWOT Analysis
Table 69. Nanosphere Nanomedicines Product and Solutions
Table 70. Nanosphere Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. UCB SA Corporate Information, Location and Competitors
Table 72. UCB SA Nanomedicines Major Business
Table 73. UCB SA Nanomedicines Total Revenue (USD Million) (2017-2018)
Table 74. UCB SA SWOT Analysis
Table 75. UCB SA Nanomedicines Product and Solutions
Table 76. UCB SA Nanomedicines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Nanomedicines Revenue (Million USD) by Players (2015-2020)
Table 78. Global Nanomedicines Revenue Share by Players (2015-2020)
Table 79. Global Nanomedicines Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Nanomedicines Revenue Market Share by Regions (2015-2020)
Table 81. North America Nanomedicines Revenue by Countries (2015-2020)
Table 82. North America Nanomedicines Revenue Market Share by Countries (2015-2020)
Table 83. Europe Nanomedicines Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Nanomedicines Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Nanomedicines Revenue by Countries (2015-2020)
Table 86. South America Nanomedicines Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Nanomedicines Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Nanomedicines Revenue Market Share by Countries (2015-2020)
Table 89. Global Nanomedicines Revenue (Million USD) by Type (2015-2020)
Table 90. Global Nanomedicines Revenue Share by Type (2015-2020)
Table 91. Global Nanomedicines Revenue Forecast by Type (2021-2025)
Table 92. Global Nanomedicines Revenue by Application (2015-2020)
Table 93. Global Nanomedicines Revenue Share by Application (2015-2020)
Table 94. Global Nanomedicines Revenue Forecast by Application (2021-2025)
Table 95. Global Nanomedicines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nanomedicines Picture
Figure 2. Global Nanomedicines Revenue Market Share by Type in 2019
Figure 3. Nanoparticles Picture
Figure 4. Nanoshells Picture
Figure 5. Nanotubes Picture
Figure 6. Nanodevices Picture
Figure 7. Others Picture
Figure 8. Nanomedicines Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Research Institute Picture
Figure 12. Global Nanomedicines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Nanomedicines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Nanomedicines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Nanomedicines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Nanomedicines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Nanomedicines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nanomedicines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nanomedicines Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Nanomedicines Revenue Market Share in 2019
Figure 21. Global Top 10 Players Nanomedicines Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Nanomedicines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Nanomedicines Revenue Market Share by Regions (2015-2020)
Figure 25. Global Nanomedicines Revenue Market Share by Regions in 2018
Figure 26. North America Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 27. Europe Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 29. South America Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 31. North America Nanomedicines Revenue Market Share by Countries (2015-2020)
Figure 32. North America Nanomedicines Revenue Market Share by Countries in 2019
Figure 33. USA Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 34. Canada Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 36. Europe Nanomedicines Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Nanomedicines Revenue Market Share by Countries in 2019
Figure 38. Germany Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 39. UK Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 40. France Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 41. Russia Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 42. Italy Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nanomedicines Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Nanomedicines Revenue Market Share by Countries in 2019
Figure 45. China Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 46. Japan Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 47. Korea Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 48. India Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 50. South America Nanomedicines Revenue Market Share by Countries (2015-2020)
Figure 51. South America Nanomedicines Revenue Market Share by Countries in 2019
Figure 52. Brazil Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Nanomedicines Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Nanomedicines Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 57. UAE Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Nanomedicines Revenue and Growth Rate (2015-2020)
Figure 60. Global Nanomedicines Revenue Share by Type (2015-2020)
Figure 61. Global Nanomedicines Revenue Share by Type in 2019
Figure 62. Global Nanomedicines Market Share Forecast by Type (2021-2025)
Figure 63. Global Nanoparticles Revenue Growth Rate (2015-2020)
Figure 64. Global Nanoshells Revenue Growth Rate (2015-2020)
Figure 65. Global Nanotubes Revenue Growth Rate (2015-2020)
Figure 66. Global Nanodevices Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Nanomedicines Revenue Share by Application (2015-2020)
Figure 69. Global Nanomedicines Revenue Share by Application in 2019
Figure 70. Global Nanomedicines Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 74. Global Nanomedicines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Nanomedicines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Nanomedicines Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Nanomedicines Revenue Market Forecast (2021-2025)
Figure 78. Europe Nanomedicines Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Nanomedicines Revenue Market Forecast (2021-2025)
Figure 80. South America Nanomedicines Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Nanomedicines Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
ナノ粒子の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nanoparticles market report pro…- 磁性ナノ粒子の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Magnetic Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Magnetic Nanoparticles…
- マグネタイトナノ粒子の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Magnetite Nanoparticles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 金属および金属酸化物ナノ粒子の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Metal and Metal Oxide Nanoparticles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metal and…
- グラフェン・2D材料・カーボンナノチューブの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Graphene,2D Materials and Carbon Nanotubes market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gr…